DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Although the use of AAV–Nano-Dysferlin showed immunofluorescence in approximately 30% of treated fibers [7], there are currently insufficient data on the application of nanodysferlin for muscle tissue restoration in dysferlinopathies.